GlassScriptPhysician profile
Michael Ross Allen
NPI 1801885116
$7,906.65
in general payments reported to CMS, 2019-2025
17 companies · $35.20 in 2025
The $35.20 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2021: $1,472 · 2022: $6,069 · 2023: $211 · 2025: $35.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $245.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cgg Medical INC | $5,211.21 | 2021-2022 | |
| Arthrex, INC. | $1,796.36 | 2022 | |
| Nevro Corp. | $335.79 | 2021-2023 | Senza |
| Organogenesis INC. | $134.63 | 2019-2023 | Puraply Antimicrobial |
| Mvp Orthopedics INC | $107.73 | 2022 | |
| Stryker Corporation | $75.81 | 2021 | |
| Fidia Pharma USA INC. | $39.91 | 2021 | |
| Globus Medical, INC. | $35.20 | 2025 | Senza |
| Smith+Nephew, INC. | $29.99 | 2019 | |
| Kci USA, INC. | $24.58 | 2021 | |
| Bioventus LLC | $20.73 | 2021 | |
| Zimvie INC. | $20.20 | 2023 | |
| Averitas Pharma INC. | $18.53 | 2023 | Qutenza |
| Lifenet Health | $17.62 | 2019 | |
| Orthofix Medical, INC. | $13.99 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alfasigma USA, INC. | $12.55 | 2021 | |
| Merck Sharp & Dohme LLC | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.